---
schema_version: '1.0'
id: government-20260728-035248
content_kind: government-document
url: https://eur-lex.europa.eu/legal-content/AUTO/?uri=OJ:L_202601826
url_hash: 03524845e1ea3538cd4ceee67c562c9f8a24b3ddbec30ba59299848612226ee6
canonical_url: https://eur-lex.europa.eu/legal-content/AUTO?uri=OJ%3AL_202601826
source: eu-eurlex
category: government/eu
category_raw: official-journal-l
country: eu
region: eu
tags: []
lang: en
published_at: '2026-07-28T22:00:00Z'
fetched_at: '2026-07-29T03:00:59.638974Z'
updated_at: '2026-07-29T03:22:22Z'
status: published
content_hash: e86180a237865ff52e959d0bca046ecd7f5613f00b87fae374208f2d98a3b20b
content_changed_at: null
license_note: full
license_basis: cc-by-4.0-decision-2011-833-eu
body_available: false
attribution: 'Source: © European Union, EUR-Lex (https://eur-lex.europa.eu/legal-content/AUTO?uri=OJ%3AL_202601826),
  CC BY 4.0 (Commission Decision 2011/833/EU). Summarized/translated by portal4Agents;
  changes were made.'
license_rule: source:eu-eurlex
summary: EUは、2026年7月28日に採択された規則により、アクティブ成分の承認期間を拡大。関連する製品には、aclonifenやbeflubutamidなどが含まれる。この規則はすべてのEU加盟国で即効力となる。
summary_source: llm
summary_en: EUは、2026年7月28日に採択された規則により、アクティブ成分の承認期間を拡大。関連する製品には、aclonifenやbeflubutamidなどが含まれる。この規則はすべてのEU加盟国で即効力となる。
provenance:
  doc_id: tag:google.com,2005:reader/item/000657b6c6d931e2
  doc_id_scheme: rss_guid
  issuer:
  - Publications Office of the European Union
  doc_type: official-journal-l
  feed_title: 5 - Acts of the Official Journal L
entities:
- name: European Commission
  type: organization
- name: July
  type: UNKNOWN
- name: THE ANSWER
  type: organization
key_facts: []
related: []
related_auto:
- name: China Department of Technology
  type: organization
  weight: 1.0
- name: United States
  type: location
  weight: 1.0
- name: Spain
  type: location
  weight: 1.0
- name: Google Workspace
  type: content
  weight: 1.0
- name: BING/トップ
  type: UNKNOWN
  weight: 1.0
title: 'OJ:L_202601826: Commission Implementing Regulation (EU) 2026/1826 of 28 July
  2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension
  of the approval periods of the active substances aclonifen, amisulbrom, Bacillus
  amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil,
  daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid,
  metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and
  S-abscisic acid'
---

# OJ:L_202601826: Commission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid

## TL;DR
EUは、2026年7月28日に採択された規則により、アクティブ成分の承認期間を拡大。関連する製品には、aclonifenやbeflubutamidなどが含まれる。この規則はすべてのEU加盟国で即効力となる。

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [OJ:L_202601826: Commission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid](https://eur-lex.europa.eu/legal-content/AUTO/?uri=OJ:L_202601826) — published 2026-07-28T22:00:00Z